Analysis of Angiotensin Converting Enzyme, Endothelial Nitric Oxide Synthase & Serotonin Gene Polymorphisms among Atrial Septal Defect Subjects with and without Pulmonary Arterial Hypertension
Authors:
- Nur Ilyana JaafarNJNur Ilyana Jaafar
- Ramachandran VasudevanRVRamachandran Vasudevan
- Patimah IsmailPIPatimah Ismail
- Ahmad Fazli Abdul AzizAAAhmad Fazli Abdul Aziz
- Nur Afiqah MohamadNMNur Afiqah Mohamad
- Geetha KandavelloGKGeetha Kandavello
- Raja Nurzatul Effah Raja AdnanRARaja Nurzatul Effah Raja Adnan
- Vinod BalasubramaniamVinod Balasubramaniam
Open Access
- 18 September 2018
- journal article
- research article
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 5 (3) , 48
Abstract
Genetic polymorphisms are variations in DNA sequences which can influence either disease susceptibility, severity, or prognosis. Pulmonary arterial hypertension (PAH) is one of the complications that occurs in certain patients who have atrial septal defect (ASD). This study seeks to determine the association of gene polymorphisms with the pathogenesis of PAH in ASD patients. This study was conducted on 30 ASD patients with PAH, and 50 ASD patients who were not diagnosed with PAH. All respondents were Malay. Patients were selected based on stringent inclusion and exclusion criteria. Molecular analyses were done to detect the genetic polymorphisms of angiotensin converting enzyme (ACE I/D), serotonin transporter (5-HTTLPR), endothelial nitric oxide synthase (eNOS) G894T, and eNOS 4b/4a. The genotypes of these genetic polymorphisms were determined using conventional PCR and PCR-RFLP methods. The PCR products were analysed using agarose gel electrophoresis. Statistical analysis was done using SPSS Version 22. Clinical characteristics, such as the diameter of ASD, mean arterial pressure (MAP), and mean pulmonary artery pressure (mPAP) differed significantly (p < 0.05). Based on the statistical analysis, ACE I/D, eNOS G894T, and eNOS 4b/4a do not contribute to the progression of PAH amongst ASD patients (p > 0.05). However, the L allele of the 5-HTTLPR gene polymorphism may have an affect on the development of PAH in ASD patients (p < 0.05).Keywords
Funding Information
- Universiti Putra Malaysia (911440)
This publication has 37 references indexed in Scilit:
- Changing demographics of pulmonary arterial hypertension in congenital heart diseaseEuropean Respiratory Review, 2010
- Association Study of Serotonin Transporter Gene Polymorphisms and Ventricular Septal Defects RelatedPossiblePulmonary Arterial Hypertension in Chinese PopulationClinical and Experimental Hypertension, 2009
- Sequence Variants in BMPR2 and Genes Involved in the Serotonin and Nitric Oxide Pathways in Idiopathic Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: Relation to Clinical Parameters and Comparison with Left Heart DiseaseRespiration, 2009
- Genetic Polymorphisms of the Serotonin Transporter, but Not the 2a Receptor or Nitric Oxide Synthetase, Are Associated with Pulmonary Hypertension in Chronic Obstructive Pulmonary DiseaseRespiration, 2009
- Association of insertion/deletion polymorphism of angiotensin-converting enzyme gene with essential hypertension and type 2 diabetes mellitus in Malaysian subjectsJournal of the Renin-Angiotensin-Aldosterone System, 2008
- Pulmonary hypertension: Past, present and futureAnnals of Thoracic Medicine, 2008
- Allelic variation in the serotonin transporter (5HTT) gene contributes to idiopathic pulmonary hypertension in childrenBiochemical and Biophysical Research Communications, 2005
- Lack of association between angiotensin converting enzyme (ACE) genotype, serum ACE activity, and haemodynamics in patients with primary pulmonary hypertensionHeart, 2003
- Angiotensin-converting enzyme DD genotype in patients with primary pulmonary hypertension: increased frequency and association with preserved haemodynamicsJournal of the Renin-Angiotensin-Aldosterone System, 2003
- Allelic Variation of Human Serotonin Transporter Gene ExpressionJournal of Neurochemistry, 1996